Bryan Reasons

Bryan Reasons is currently the Executive Vice President and Chief Financial Officer at Mallinckrodt. Bryan has previously held positions as the CFO at Impax Laboratories, Vice President Finance at Teva Pharmaceuticals, and Vice President Finance and Corp Accounting at Cephalon. Bryan began their career at PricewaterhouseCoopers as a Senior Manager in Audit.

Bryan Reasons pursued an MBA in Accounting at Widener University and a BS in Finance at Penn State University.

Some individuals on their team include Stephen Welch - EVP & Head of Specialty Generics, Henriette Nielsen - EVP & Chief Transformation Officer, and Mark Tyndall - EVP & Chief Legal Officer & Corporate Secretary.